Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2

Nature Genetics

Volumn 47, Issue 9, 2015, Pages 1056-1060

  Ungewickell, Alexander ^a   Bhaduri, Aparna ^a   Rios, Eon ^a   Reuter, Jason ^a   Lee, Carolyn S ^a   Mah, Angela ^a   Zehnder, Ashley ^a   Ohgami, Robert ^b   Kulkarni, Shashikant ^c   Armstrong, Randall ^a   Weng, Wen Kai ^a   Gratzinger, Dita ^b   Tavallaee, Mahkam ^a   Rook, Alain ^d   Snyder, Michael ^a   Kim, Youn ^a   Khavari, Paul A ^a,e  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR RECEPTOR 2; ANTINEOPLASTIC AGENT; CTLA4 PROTEIN, HUMAN; ONCOPROTEIN;

ARTICLE; CANCER PATIENT; CELL MUTANT; CELL SURVIVAL; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; MYCOSIS FUNGOIDES; NFKB2 GENE; ONCOGENE K RAS; PLCG1 GENE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEZARY SYNDROME; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TNFRSF1B GENE; DRUG RESISTANCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOMICS; METABOLISM; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; SKIN TUMOR; TUMOR CELL LINE;

ANTIGENS, CD28; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BORTEZOMIB; CELL LINE, TUMOR; CTLA-4 ANTIGEN; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; MYCOSIS FUNGOIDES; ONCOGENE PROTEINS, FUSION; POINT MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEZARY SYNDROME; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84940607197     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3370     Document Type: Article

References (30)

1. Wong, H.K., Mishra, A., Hake, T. & Porcu, P. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br. J. Haematol. 155, 150-166 (2011).
2. Kiessling, M.K. et al. High-throughput mutation profling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/ MEK signaling cascade. Blood 117, 2433-2440 (2011).
3. Vaqué, J.P. et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood 123, 2034-2043 (2014).
4. So, T. & Croft, M. Regulation of PI-3-kinase and Akt signaling in T lymphocytes and other cells by TNFR family molecules. Front. Immunol. 4, 139 (2013).
5. Lee, C.S. et al. Transcriptome sequencing in Sezary syndrome identifes Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. Blood 120, 3288-3297 (2012).
6. Newman, A.M. et al. FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics 30, 3390-3393 (2014).
7. Migliazza, A. et al. Heterogeneous chromosomal aberrations generate 3′ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood 84, 3850-3860 (1994).
8. Zhang, J., Chang, C.C., Lombardi, L. & Dalla-Favera, R. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. Oncogene 9, 1931-1937 (1994).
9. Vasmatzis, G. et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 120, 2280-2289 (2012).
10. Nguyen, L.T. & Ohashi, P.S. Clinical blockade of PD1 and LAG3-potential mechanisms of action. Nat. Rev. Immunol. 15, 45-56 (2015).
11. Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation. Science 281, 1305-1308 (1998).
12. Shin, J.H. et al. Positive conversion of negative signaling of CTLA4 potentiates antitumor effcacy of adoptive T-cell therapy in murine tumor models. Blood 119, 5678-5687 (2012).
13. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480-489 (2011).
14. Sekulic, A. et al. Personalized treatment of Sezary syndrome by targeting a novel CTLA4:CD28 fusion. Mol. Genet. Genomic Med. 3, 130-136 (2015).
15. Cabal-Hierro, L. & Lazo, P.S. Signal transduction by tumor necrosis factor receptors. Cell. Signal. 24, 1297-1305 (2012).
16. van Doorn, R. et al. Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 113, 127-136 (2009).
17. Heemann, C. et al. Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma. Clin. Cancer Res. 18, 3637-3647 (2012).
18. Lin, W.M. et al. Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients. J. Invest. Dermatol. 132, 188-197 (2012).
19. Rodríguez, M. et al. NF-κB signal triggering and termination by tumor necrosis factor receptor 2. J. Biol. Chem. 286, 22814-22824 (2011).
20. Zinzani, P.L. et al. Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. J. Clin. Oncol. 25, 4293-4297 (2007).
21. Acuto, O. & Michel, F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3, 939-951 (2003).
22. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
23. DePristo, M.A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
24. Koboldt, D.C. et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283-2285 (2009).
25. Deng, X. SeqGene: a comprehensive software solution for mining exome- and transcriptome-sequencing data. BMC Bioinformatics 12, 267 (2011).
26. Ng, S.B. et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272-276 (2009).
27. Liu, X., Jian, X. & Boerwinkle, E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum. Mutat. 34, E2393-E2402 (2013).
28. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
29. Shi, J. & Walker, M.G. Gene set enrichment analysis (GSEA) for interpreting gene expression profles. Curr. Bioinformatics 2, 133-137 (2007).
30. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).